Search results for 'US Generics'

MFs to Create LONG-TERM Wealth

MFs to Create LONG-TERM Wealth

Rediff.com9 Aug 2021

Omkeshwar Singh, Head, Rank MF, a mutual fund investment platform, answers your queries.

Glenmark eyes US mart; ties up with Aspen

Glenmark eyes US mart; ties up with Aspen

Rediff.com8 May 2006

Pharmaceutical firm Glenmark said on Monday it had signed a supply and marketing agreement with Aspen USA for joint manufacturing and sales of three generic products in US.

Merck bid: Ranbaxy makes it to next round

Merck bid: Ranbaxy makes it to next round

Rediff.com16 Mar 2007

Ranbaxy is understood to have emerged as the sole Indian pharma entity to have moved into the next round of bidding for the generic business of Merck, even as compatriot Cipla claimed to be "very much in the race."

The rise of the Indian pharma cos

The rise of the Indian pharma cos

Rediff.com4 Apr 2006

Sun Pharma has all the reasons to cheer Ranbaxy deal

Sun Pharma has all the reasons to cheer Ranbaxy deal

Rediff.com11 Apr 2014

One of the suitors says that Ranbaxy's Indian portfolio alone is worth $2 billion, or approximately Rs 11,900 crore.

Brand Ranbaxy may be axed soon

Brand Ranbaxy may be axed soon

Rediff.com8 Apr 2014

Sun's acquisition of Ranbaxy would create the fifth-largest specialty generics company in the world and the largest Indian pharma company, with an estimated revenue of $4.2 billion.

What lies ahead for Sun Pharma post Ranbaxy merger approval

What lies ahead for Sun Pharma post Ranbaxy merger approval

Rediff.com31 Mar 2015

Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.

Drugs to be cheaper now

Drugs to be cheaper now

Rediff.com25 May 2006

Keeping its word to make drugs affordable to consumers, the government on Thursday announced caps on margins on the sale of pharmaceutical products.

Sons rise at Alembic

Sons rise at Alembic

Rediff.com3 Sep 2005

Ranbaxy, Reddy's vie for US cholesterol drug mart

Ranbaxy, Reddy's vie for US cholesterol drug mart

Rediff.com3 May 2006

Simvastatin goes off patent in late June; Ranbaxy gets 180-day exclusivity period; Dr Reddy's-Merck will be third player.

Bigger role seen for biopharma

Bigger role seen for biopharma

Rediff.com18 Apr 2006

Govt issues guidelines for reopening of gyms, yoga centres

Govt issues guidelines for reopening of gyms, yoga centres

Rediff.com3 Aug 2020

The guidelines lay down the processes and premises redesigning, including proper placement of equipments. Yoga institutes and gymnasiums have been asked to plan the floor area based on four metres squared per person.

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Greet with namaste: PM amid coronavirus scare

Greet with namaste: PM amid coronavirus scare

Rediff.com7 Mar 2020

The entire world is taking up the habit of 'namaste', Modi said.

Aurobindo Pharma embroiled in patent cases in the US

Aurobindo Pharma embroiled in patent cases in the US

Rediff.com28 Apr 2014

According to the petition copies, Hospira has alleged that Aurobindo's Abbreviated New Drug Application (ANDA) to make generic version of dexmedetomidine hydrochloride injection would infringe its patented drug Precedex.

'Our risk is now being managed'

'Our risk is now being managed'

Rediff.com10 Mar 2006

The US continues to be the most important part of our overseas portfolio

Coronavirus: No shortage of medicines, says govt

Coronavirus: No shortage of medicines, says govt

Rediff.com5 Mar 2020

'There is no shortage of any APIs (active pharmaceutical ingredients) in the country'

Pfizer set to buy Allergan for more than $150 bn

Pfizer set to buy Allergan for more than $150 bn

Rediff.com23 Nov 2015

The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.

Next in DU English literature syllabus: How to write a Facebook post

Next in DU English literature syllabus: How to write a Facebook post

Rediff.com26 Apr 2017

The varsity had recently proposed adding bestselling author Chetan Bhagat's debut novel "Five Point Someone" as a "General Elective" paper for students of honours courses other than English, a choice that drew sharp reactions on the social media.

10 reasons why your CV was REJECTED!

10 reasons why your CV was REJECTED!

Rediff.com9 Oct 2019

Unless you are a fresher, you should not circulate a generic CV for all openings, says Achin Bhattacharyya.

Wockhardt gets US nod for Zonisamide

Wockhardt gets US nod for Zonisamide

Rediff.com26 Dec 2005

Wockhardt has received United States Food & Drug Administration approval to market Zonisamide capsules.

Vaccine will be available to all

Vaccine will be available to all

Rediff.com17 Dec 2020

The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.

US groups criticise India's drug, tech, farm policies

US groups criticise India's drug, tech, farm policies

Rediff.com14 Mar 2013

Last year, India's agricultural exports to the United States topped $5 billion.

Ranbaxy launches Clarithromycin in US

Ranbaxy launches Clarithromycin in US

Rediff.com24 May 2005

Ranbaxy Laboratories Ltd on Tuesday launched its approved generic formulation of Clarithromycin immediate release tablets in the US market.

Rise and fall in Indo-US trade over the years

Rise and fall in Indo-US trade over the years

Rediff.com29 Sep 2014

Trade has grown steadily since 2004, before flattening out in the past couple of years.

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy 'systematically violated' norms: Whistleblower

Rediff.com14 May 2013

The generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas in India and included acne drug Sotret, epilepsy and nerve pain drug gabapentin and antibiotic ciprofloxacin.

Ranbaxy recalls AIDS drugs

Ranbaxy recalls AIDS drugs

Rediff.com10 Nov 2004

Ranbaxy Laboratories has withdrawn all of its generic versions of antiretroviral drugs from World Health Organization's list of approved HIV medicines, saying it's uncertain they are biologically the same as the patented drugs.

How Gujarat plans to help its pharma companies

How Gujarat plans to help its pharma companies

Rediff.com25 Apr 2013

The state govt has raised drug procurement budget.

GlaxoSmithKline sues Dr Reddy's

GlaxoSmithKline sues Dr Reddy's

Rediff.com31 Dec 2003

GlaxoSmithKline has filed a lawsuit in a United States court against Dr Reddy's Laboratories alleging infringement of patent rights of a generic version of 'Imitrex' drug, used for the treatment of migraine.

Pharma R&D: Basic drug research only a part

Pharma R&D: Basic drug research only a part

Rediff.com22 Apr 2013

Spending allocation covers salaries, consultancy, litigation, material expense and regulatory costs.

Patent row: Pfizer sues Ranbaxy

Patent row: Pfizer sues Ranbaxy

Rediff.com22 Feb 2005

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

7 habits of highly successful people

7 habits of highly successful people

Rediff.com4 Sep 2013

Practice these seven easy habits and you'll be amazed at the results, says Aditya Prasad, chief evangelist at Perfios.com.

India should take US pharma complaints seriously

India should take US pharma complaints seriously

Rediff.com25 Jun 2013

The worry is that India's cavalier approach to intellectual property may catch on in other parts of the developing world

How the jewellers plan to achieve $60-billion export target

How the jewellers plan to achieve $60-billion export target

Rediff.com7 Apr 2017

Prime Minister Narendra Modi had asked exporters to prepare a strategy for the next five years and start working in that direction.